Cipla wins FDA approval for generic Advair Diskus in all strengths Jul 28, 2026 08:00AM
Cipla Receives U.S. FDA Approval for Generic Advair Diskus® Jul 28, 2026 08:00AM
Cipla receives FDA approval for first generic Ventolin HFA Apr 23, 2026 09:04AM
Cipla Receives U.S. FDA Approval for First AB-Rated Generic of Ventolin® HFA Apr 23, 2026 09:04AM
Cipla Expands U.S. Respiratory Portfolio with Approval of Nintedanib Capsules (100mg & 150mg) for Idiopathic Pulmonary Fibrosis Apr 2, 2026 11:11PM
View Older Stories

Feb 27, 2026 11:28AM Cipla strengthens US portfolio with the launch of generic Saxenda® (Liraglutide Injection) for weight management therapy
Nov 17, 2025 08:30AM Cipla USA Strengthens Lung Leadership with Community Wellness Initiatives
Mar 18, 2025 04:00AM Cipla and Formosa sign multi-regional licensing deal for Clobetasol Suspension
May 22, 2024 03:26PM Cipla receives final approval for the generic version of Somatuline® Depot (Lanreotide) Injection 120 mg/ 0.5 mL, 90 mg/0.3 mL, 60 mg/0.2 mL
Jan 8, 2024 08:00AM Cipla announces joint venture in the United States with Kemwell Biopharma and Manipal Education & Medical Group for global development and commercialisation of innovative Cell therapy products
Aug 7, 2023 11:08AM Cipla USA Earns 2023 Great Place To Work Certification™
Dec 29, 2022 01:25PM Cipla EU to Invest EUR 15 million in Ethris, initiating a strategic collaboration
Nov 29, 2022 10:00PM CIPLA ANNOUNCES LAUNCH OF LEUPROLIDE ACETATE INJECTION DEPOT (22.5Mg)
Sep 7, 2022 07:45AM Cipla receives USFDA approval for generic version of Revlimid® (Lenalidomide capsules)
Jun 14, 2022 08:22AM Cipla and DNDi launch child-friendly 4-in-1 antiretroviral treatment for young children living with HIV in South Africa
Jan 12, 2022 07:09AM Cipla to Present at the 40th Annual J.P. Morgan Healthcare Conference
Aug 12, 2021 07:00AM Cipla receives final approval for generic version of Novartis Pharmaceuticals Corporation Durezol® (Difluprednate Ophthalmic Emulsion 0.05%)
Jun 23, 2021 07:00AM Cipla receives final approval for generic version of Sunovion Pharmaceuticals, Inc.'s Brovana® (Arformoterol Tartrate Inhalation Solution 15 mcg/ 2mL)
Mar 23, 2021 10:30AM Cipla Therapeutics and SIGA Technologies Announce Strategic Partnership to support innovation and provide access to novel antibacterial drugs against biothreats
Mar 2, 2021 12:07PM Cipla Gulf and Alvotech Expand Partnership for Commercialization of Biosimilars in Australia and New Zealand
Mar 2, 2021 08:00AM Cipla receives final approval for generic version of GlaxoSmithKline's IMITREX® (Sumatriptan Nasal Spray, 20 mg)
Jan 12, 2021 08:30AM Cipla to Present at the 39th Annual J.P. Morgan Healthcare Conference
Dec 11, 2020 08:03AM Cipla Announces Settlement of REVLIMID® (lenalidomide) Capsules Patent Litigation
Nov 18, 2020 02:25AM Cipla launches 'Covi-G' for COVID-19 rapid antibody detection
Sep 28, 2020 08:07AM Cipla receives final approval for generic version of Biogen IDEC Inc.'s Tecfidera® (Dimethyl Fumarate DR Capsules 120mg, 240mg and 120mg/240mg Starter Pack)
Aug 21, 2020 06:00AM Cipla and Stempeutics collaborate for launch of Stempeucel®, first 'Made in India' Cell Therapy to treat Critical Limb Ischemia (CLI)
Jul 14, 2020 06:00AM Cipla Receives Final Approval for Generic Version of Shire's Firazyr® (Icatibant Injectable Pre-Filled Syringe 30mg/3mL)
Jun 22, 2020 06:00AM Cipla Launches CIPREMI (remdesivir Lyophilised Powder for Injection 100 mg), the Only U.S. FDA Approved Emergency Use Authorisation (EUA) Treatment for Patients With Severe COVID-19 Disease
May 21, 2020 06:00AM Cipla Receives Final Approval for Generic Version of Migranal® (Dihydroergotamine Mesylate Nasal Spray 4mg/mL) With a Competitive Generic Therapy Designation
May 19, 2020 06:00AM Cipla Files ANDA for Generic Version of GSK's Advair Diskus®
May 13, 2020 05:29AM Cipla Enters Into a Licensing Agreement With Gilead to Expand Access to COVID-19 Treatment
Apr 9, 2020 09:04AM Cipla Receives Final Approval for Generic Version of Proventil® HFA Inhalation Aerosol (Albuterol Sulfate Inhalation Aerosol 90mcg (Base)/Actuation)
Mar 27, 2020 08:18AM Cipla Receives Final Approval for Generic Version of AstraZeneca Pharmaceutical's Nexium® (Esomeprazole for Oral Suspension 10mg, 20mg and 40mg)
Jul 29, 2019 12:00AM Alvotech and Cipla Gulf Enter Into a Partnership for the Commercialization of Key Biosimilar in Select Emerging Markets
Jul 24, 2019 01:47PM Cipla USA Furthers AMR Stewardship With Acquisition of Key Anti-infective ZEMDRI™ (IV Plazomicin)
Jul 22, 2019 12:37AM InvaGen (a Cipla Subsidiary) Receives Final Approval for Generic Version of Pfizer's Lyrica® (Pregabalin Capsules, 25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg, 300mg)
Apr 15, 2019 09:10AM Pulmatrix (PULM), Cipla Technologies Enter Agreement for Development and Commercialization of Pulmazole
Apr 15, 2019 09:00AM Pulmatrix and Cipla Technologies LLC enter into Definitive Agreement for the Development and Commercialization of Pulmazole™
Apr 1, 2019 09:00AM Pulmatrix Enters Into Binding Term Sheet with Cipla Technologies LLC for the Development and Commercialization of Pulmazole
Jan 14, 2019 08:08AM Bio-Thera Solutions Ltd Partners with Cipla Ltd to Market Key Cancer Biosimilar
View Older Stories